Novanta Inc.
TechnologyNASDAQ:NOVT · NASDAQ Global Select
-$1.88 today
Vol 0.44M · Avg 0.44M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
4.1%
avg 11.0%
ROIC
5.5%
avg 7.0%
ROA
3.0%
avg 5.7%
Analysis
ROIC is currently the strongest return metric at 5.5% versus its period average of 7.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Matthijs Glastra | Chief Executive Officer & Chairman of the Board | $1.77M | — | 57 | $42,723.00 | 0.12% |
John Lesica | Co-Chief Operating Officer of Medical Solutions | $1.20M | — | 50 | $9,041.00 | 0.03% |
Robert J. Buckley | Chief Financial Officer | $945,741.00 | — | 52 | $106,573.00 | 0.30% |
Chuck Ravetto | Co-Chief Operating Officer of Automation Enabling Technologies | $773,209.00 | — | 55 | $16,359.00 | 0.05% |
Charles G. Ravetto | Co-Chief Operating Officer of Automation Enabling Technologies | $773,209.00 | — | 55 | $16,359.00 | 0.05% |
Liam Weston | Chief Human Resources Officer | $540,198.00 | — | — | — | — |
Alexander Manganiello | General Counsel & Corporate Secretary | $237,831.00 | — | 59 | $4,111.00 | 0.01% |
Sarah Betadam | Chief Information Officer & Chief Information Security Officer | — | — | — | — | — |
Heinrich Dreyer | Group President of Medical Solutions | — | — | — | — | — |
John Joseph Burke | Chief Accounting Officer & Corporate Controller | — | — | 44 | $9,041.00 | 0.03% |
Ray Nash | Corporate Finance Leader & IR | — | — | — | — | — |
Nissia Sabri | Senior Vice President of Corporate Development | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
39
$10.42M
Net Sentiment
$10.42M
Net selling
Most Active
Glastra Matthijs
29 transactions
1–10 of 39
Analysis
Insiders reported 0 buys worth $0.00 and 39 sells worth $10.42M over the last 12 months. That adds up to net selling of $10.42M. Glastra Matthijs was the most active insider with 29 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +20.7% | +12.4% (12yr)2 analysts |
| Revenue | N/A | N/A | +11.2% | +9.6% (12yr)2 analysts |
| Net Income | N/A | N/A | +22.2% | +12.8% (12yr)2 analysts |
| EBIT | N/A | N/A | +24.5% | +14.1% (12yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +24.5% over three years. Forward estimates point to EBIT at +14.1% (12yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Vicor Corporation
NASDAQ:VICR
$13.70B
ESCO Technologies Inc.
NYSE:ESE
$8.13B
Plexus Corp.
NASDAQ:PLXS
$7.89B
Sensata Technologies Holding plc
NYSE:ST
$7.33B
Belden Inc.
NYSE:BDC
$4.48B
Vontier Corporation
NYSE:VNT
$4.12B
Badger Meter, Inc.
NYSE:BMI
$3.84B
OSI Systems, Inc.
NASDAQ:OSIS
$3.72B
Itron, Inc.
NASDAQ:ITRI
$3.57B
Webull Corporation Class A Ordinary Shares
NASDAQ:BULL
$3.48B
Who manages NOVT?
Novanta Inc. (NOVT) lists 12 active executives. The top listed executive is John Lesica, Co-Chief Operating Officer of Medical Solutions.
Are NOVT insiders buying or selling?
Recent insider activity shows net selling of $16.70M.
Explore More
Continue the stock analysis
Jump to another research area for this company.